Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 63.30% is in line with its 5-year average of 62.07%, around the middle of its 5-year range (56.29%–76.51%).
10.13% below its 12-month average of 70.44%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 76.51%.
GROSS MARGIN
63.30%
GROSS MARGIN AVG TTM
70.44%
GROSS MARGIN AVG 3Y
65.23%
GROSS MARGIN AVG 5Y
62.07%
GROSS MARGIN AVG 10Y
60.43%
GROSS MARGIN AVG 15Y
58.47%
GROSS MARGIN AVG 20Y
67.47%
CURRENT VS TTM AVG
-10.13%
CURRENT VS 3Y AVG
-2.96%
CURRENT VS 5Y AVG
+1.98%
CURRENT VS 10Y AVG
+4.75%
CURRENT VS 15Y AVG
+8.26%
CURRENT VS 20Y AVG
-6.18%
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+56.53%
vs the sector median at left
OptimizeRx Corp.
Market Cap
$166.35M
Gross Margin
63.30%
TTM Avg
70.44%
3Y Avg
65.23%
5Y Avg
62.07%
Market Cap
$164.16M
Gross Margin
42.60%
TTM Avg
53.28%
3Y Avg
52.45%
5Y Avg
54.03%
Market Cap
$163.00M
Gross Margin
63.55%
TTM Avg
56.95%
3Y Avg
54.72%
5Y Avg
65.55%
Market Cap
$169.85M
Gross Margin
67.59%
TTM Avg
75.78%
3Y Avg
75.92%
5Y Avg
75.58%
Market Cap
$158.63M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$173.23M
Gross Margin
83.01%
TTM Avg
91.50%
3Y Avg
95.75%
5Y Avg
97.17%
Market Cap
$173.79M
Gross Margin
99.69%
TTM Avg
100.00%
3Y Avg
-73.48%
5Y Avg
-190.92%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $166.35M | 63.30% | 70.44% | 65.23% | 62.07% |
| Quanterix Corporation (QTRX)vs › | $164.16M | 42.60% | 53.28% | 52.45% | 54.03% |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | 63.55% | 56.95% | 54.72% | 65.55% |
| PepGen Inc. (PEPG)vs › | $162.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | 67.59% | 75.78% | 75.92% | 75.58% |
| MediWound Ltd. (MDWD)vs › | $170.85M | 15.46% | 16.11% | 25.27% | 28.77% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | 0.00% | 0.00% | 0.00% | 16.67% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | 83.01% | 91.50% | 95.75% | 97.17% |
| Cue Biopharma, Inc. (CUE)vs › | $173.79M | 99.69% | 100.00% | -73.48% | -190.92% |
| Inogen, Inc. (INGN)vs › | $158.12M | 48.89% | 46.84% | 43.63% | 44.77% |
Gross Margin
63.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 76.51% |
| 2026-03-31 | 69.89% |
| 2025-12-31 | 74.75% |
| 2025-09-30 | 67.20% |
| 2025-06-30 | 63.83% |
| 2025-03-31 | 60.85% |
| 2024-12-31 | 68.15% |
| 2024-09-30 | 63.10% |
| 2024-06-30 | 62.22% |
| 2024-03-31 | 61.98% |
| 2023-12-31 | 62.89% |
| 2023-09-30 | 60.01% |
| 2023-06-30 | 56.63% |
| 2023-03-31 | 57.16% |
| 2022-12-31 | 63.37% |
| 2022-09-30 | 62.45% |
| 2022-06-30 | 64.31% |
| 2022-03-31 | 59.00% |
| 2021-12-31 | 61.00% |
| 2021-09-30 | 56.29% |
| 2021-06-30 | 59.04% |
| 2021-03-31 | 54.54% |
| 2020-12-31 | 52.38% |
| 2020-09-30 | 57.17% |
| 2020-06-30 | 58.57% |
| 2020-03-31 | 57.26% |
| 2019-12-31 | 60.61% |
| 2019-09-30 | 60.40% |
| 2019-06-30 | 61.65% |
| 2019-03-31 | 69.60% |
| 2018-12-31 | 62.22% |
| 2018-09-30 | 58.10% |
| 2018-06-30 | 56.14% |
| 2018-03-31 | 51.17% |
| 2017-12-31 | 62.97% |
| 2017-09-30 | 45.09% |
| 2017-06-30 | 43.98% |
| 2017-03-31 | 35.80% |
| 2016-12-31 | 61.95% |
| 2016-09-30 | 59.50% |
| 2016-06-30 | 51.77% |
| 2016-03-31 | 49.26% |
| 2015-12-31 | 53.52% |
| 2015-09-30 | 47.97% |
| 2015-06-30 | 48.26% |
| 2015-03-31 | 49.15% |
| 2014-12-31 | 37.30% |
| 2014-09-30 | 46.99% |
| 2014-06-30 | 62.86% |
| 2014-03-31 | 62.14% |
| 2013-12-31 | 36.31% |
| 2013-09-30 | 72.55% |
| 2013-06-30 | 82.14% |
| 2013-03-31 | 93.99% |
| 2012-12-31 | -38.82% |
| 2012-09-30 | 95.44% |
| 2012-06-30 | 85.22% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | -51.91% |
| 2011-06-30 | -46.36% |
| 2011-03-31 | 80.85% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | -17436.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | -10106.23% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
